Oligometastatic Hepatocellular Carcinoma
1 clinical trials · Condition
◉ Watch Oligometastatic Hepatocellular Carcinoma
| Record | Firm | Date |
|---|---|---|
| Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy (NCT07537777) | Nanfang Hospital, Southern Medical University | 2026-04-20 |
Track Oligometastatic Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.